ArticleChemistryOpen2026
Exploration of the Phytochemical and Antidiabetic Properties of Teucrium polium: A Natural Asset for Type 2 Diabetes Management.
Article in ChemistryOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phenolic Profile, Antioxidant Capacity, and Alpha-Glucosidase Inhibitory Activity of High-Oil Corn Doubled-Haploid Hybrids from Mexico.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Type 2 diabetes (T2D) is characterized by hyperglycemia due to impaired insulin utilization, and current therapies face notable limitations. This study investigated the chemical composition and biological activities of Teucrium polium essential oils and extracts, with a focus on their antidiabetic, antimicrobial, and antioxidant properties. Essential oil from aerial parts (yield 1.65%) was obtained by hydrodistillation; extracts were prepared by aqueous decoction (E0) and Soxhlet (aqueous, E1; hydroethanolic, E2). HPLC-UV-Vis-ESI-MS and GC-MS identified bioactives. The oil was dominated by carvacrol (28.10%), thymol (26.28%), γ-terpinene (12.11%), and o-cymene (15.59%). E0 was rich in poliumoside (36.45%); E1 contained verbascoside (9.42%) and isorhamnetin-3-O-rutinoside (9.68%); E2 was dominated by apigenin-7-rutinoside (21.18%). Antioxidant assays showed 85% DPPH inhibition at 100 µgmL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.